HK1163676A1 - Bicyclic heterocyclic compound - Google Patents
Bicyclic heterocyclic compoundInfo
- Publication number
- HK1163676A1 HK1163676A1 HK12104295.0A HK12104295A HK1163676A1 HK 1163676 A1 HK1163676 A1 HK 1163676A1 HK 12104295 A HK12104295 A HK 12104295A HK 1163676 A1 HK1163676 A1 HK 1163676A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- heterocyclic compound
- bicyclic heterocyclic
- bicyclic
- compound
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008332796 | 2008-12-26 | ||
| PCT/JP2009/071529 WO2010074193A1 (fr) | 2008-12-26 | 2009-12-25 | Nouveau composé hétérocyclique à cycle double |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1163676A1 true HK1163676A1 (en) | 2012-09-14 |
Family
ID=42287798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12104295.0A HK1163676A1 (en) | 2008-12-26 | 2012-05-02 | Bicyclic heterocyclic compound |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8471038B2 (fr) |
| EP (1) | EP2380881B1 (fr) |
| JP (1) | JP5143916B2 (fr) |
| KR (1) | KR101663336B1 (fr) |
| CN (1) | CN102264707B (fr) |
| AU (1) | AU2009331179B2 (fr) |
| BR (1) | BRPI0924126B1 (fr) |
| CA (1) | CA2748251C (fr) |
| CY (1) | CY1118862T1 (fr) |
| DK (1) | DK2380881T3 (fr) |
| ES (1) | ES2620446T3 (fr) |
| HK (1) | HK1163676A1 (fr) |
| IL (1) | IL213690A0 (fr) |
| LT (1) | LT2380881T (fr) |
| MX (1) | MX2011006904A (fr) |
| PL (1) | PL2380881T3 (fr) |
| PT (1) | PT2380881T (fr) |
| RU (1) | RU2518073C2 (fr) |
| SI (1) | SI2380881T1 (fr) |
| TW (1) | TWI436986B (fr) |
| WO (1) | WO2010074193A1 (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2380881T (lt) * | 2008-12-26 | 2017-04-10 | Sumitomo Dainippon Pharma Co., Ltd. | Naujas biciklinis heterociklinis junginys |
| JP5667934B2 (ja) * | 2010-06-28 | 2015-02-12 | 大日本住友製薬株式会社 | 新規２環性複素環化合物からなる医薬 |
| CN101985453B (zh) * | 2010-10-18 | 2012-10-31 | 国家海洋局第三海洋研究所 | 一种4-氨基吡啶衍生物及其制备方法与应用 |
| WO2012116440A1 (fr) * | 2011-03-03 | 2012-09-07 | Zalicus Pharmaceuticals Ltd. | Inhibiteurs de type benzimidazole du canal sodique |
| US9006477B2 (en) * | 2011-07-07 | 2015-04-14 | Ihara Chemical Industry Co., Ltd. | Method for producing nitrobenzene compound |
| EP2797896A1 (fr) * | 2011-12-28 | 2014-11-05 | Allergan, Inc. | Dérivés benzimidazole en tant que bloqueurs sélectifs du courant de sodium persistant |
| US9944634B2 (en) * | 2012-10-31 | 2018-04-17 | Raqualia Pharma Inc. | Pyrazolopyridine derivatives as TTX-S blockers |
| JP2016169161A (ja) * | 2013-07-19 | 2016-09-23 | 大日本住友製薬株式会社 | 新規イミダゾピリジン化合物 |
| US9828348B2 (en) | 2013-11-08 | 2017-11-28 | Purdue Pharma L.P. | Benzimidazole derivatives and use thereof |
| KR102435145B1 (ko) | 2013-12-13 | 2022-08-24 | 버텍스 파마슈티칼스 인코포레이티드 | 나트륨 채널의 조절제로서의 피리돈 아미드의 프로드럭 |
| JP2016079168A (ja) * | 2014-10-17 | 2016-05-16 | 塩野義製薬株式会社 | ９員縮合環誘導体 |
| WO2018168899A1 (fr) | 2017-03-15 | 2018-09-20 | 大日本住友製薬株式会社 | Procédé de production d'un dérivé de benzimidazole |
| JP7175878B2 (ja) * | 2017-03-15 | 2022-11-21 | 住友ファーマ株式会社 | 新規ベンズイミダゾロン化合物およびその医薬用途 |
| IL270680B (en) | 2017-05-16 | 2022-06-01 | Vertex Pharma | Deuterium-converted pyridone amides and their prodrugs as sodium channel modulators |
| BR112020000553A2 (pt) | 2017-07-11 | 2020-07-21 | Vertex Pharmaceuticals Incorporated | carboxamidas como moduladores de canal de sódio |
| US20190343817A1 (en) | 2018-02-12 | 2019-11-14 | Vertex Pharmaceuticals Incorporated | Method of treating pain |
| WO2020017585A1 (fr) | 2018-07-19 | 2020-01-23 | 大日本住友製薬株式会社 | Préparation médicinale à usage externe |
| WO2020146612A1 (fr) | 2019-01-10 | 2020-07-16 | Vertex Pharmaceuticals Incorporated | Esters et carbamates utilisés en tant que modulateurs de canaux sodiques |
| WO2020146682A1 (fr) | 2019-01-10 | 2020-07-16 | Vertex Pharmaceuticals Incorporated | Carboxamides utilisés en tant que modulateurs de canaux sodiques |
| WO2020176763A1 (fr) | 2019-02-27 | 2020-09-03 | Vertex Pharmaceuticals Incorporated | Forme posologique comprenant un promédicament inhibiteur de canal sodique na 1,8 |
| WO2020219867A1 (fr) | 2019-04-25 | 2020-10-29 | Vertex Pharmaceuticals Incorporated | Compositions de co-cristaux d'amide de pyridone pour le traitement de la douleur |
| BR112022010924A2 (pt) | 2019-12-06 | 2022-09-06 | Vertex Pharma | Tetra-hidrofuranos substituídos como moduladores de canais de sódio |
| CN116615184A (zh) | 2020-12-23 | 2023-08-18 | 住友制药株式会社 | 口服固体制剂 |
| WO2022256676A1 (fr) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | Analogues de tétrahydrofurane substitués utiles en tant que modulateurs de canaux sodiques |
| PE20241335A1 (es) | 2021-06-04 | 2024-07-03 | Vertex Pharma | N-(hidroxialquil (hetero)aril) tetrahidrofurano carboxamidas como moduladores de canales de sodio |
| WO2022256702A1 (fr) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | Tétrahydrofuran-2-carboxamides substitués utiles en tant que modulateurs de canaux sodiques |
| EP4346818A1 (fr) | 2021-06-04 | 2024-04-10 | Vertex Pharmaceuticals Incorporated | Formes galéniques solides et schémas posologiques comprenant du (2r,3s,4s,5r)-4-[[3-(3,4-difluoro-2-méthoxy-phényl)-4,5-diméthyl-5-(trifluorométhyl)tétrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide |
| WO2022256679A1 (fr) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | Analogues de n-(hydroxyalkyl(hétéro)aryl)tétrahydrofurane carboxamide en tant que modulateurs de canaux sodiques |
| CA3221960A1 (fr) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | Tetrahydrofuranes a substitution hydroxy et (halo)alkoxy utiles en tant que modulateurs de canaux sodiques |
| WO2023205468A1 (fr) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Composés hétéroaryle pour le traitement de la douleur |
| WO2023205463A1 (fr) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Composés hétéroaryles pour le traitement de la douleur |
| US20230382910A1 (en) | 2022-04-22 | 2023-11-30 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
| WO2023205465A1 (fr) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Composés hétéroaryles pour le traitement de la douleur |
| WO2024123815A1 (fr) | 2022-12-06 | 2024-06-13 | Vertex Pharmaceuticals Incorporated | Procédé de synthèse de modulateurs de tétrahydrofurane substitués de canaux sodiques |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19705450A1 (de) * | 1997-02-13 | 1998-08-20 | Merck Patent Gmbh | Bicyclische aromatische Aminosäuren |
| MXPA03003039A (es) * | 2000-10-06 | 2003-10-15 | Neurogen Corp | Derivados de indola y bencimidazola como moduladores del receptor crf. |
| AU2002232541A1 (en) * | 2000-11-21 | 2002-06-03 | Vertex Pharmaceuticals Incorporated | Imidazole and benzimidazole caspase inhibitors and uses thereof |
| RU2006118312A (ru) * | 2003-10-28 | 2007-12-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Бензимидазолы, полезные в качестве модуляторов ионных каналов |
| WO2008033739A2 (fr) * | 2006-09-12 | 2008-03-20 | Neurogen Corporation | Dérivés de benzimidazolecarboxamide |
| EP2234487A4 (fr) * | 2007-12-19 | 2011-09-07 | Scripps Research Inst | Anilides et analogues utilisés comme inhibiteurs de la rho kinase |
| LT2380881T (lt) * | 2008-12-26 | 2017-04-10 | Sumitomo Dainippon Pharma Co., Ltd. | Naujas biciklinis heterociklinis junginys |
| WO2020017585A1 (fr) * | 2018-07-19 | 2020-01-23 | 大日本住友製薬株式会社 | Préparation médicinale à usage externe |
-
2009
- 2009-12-25 LT LTEP09834989.7T patent/LT2380881T/lt unknown
- 2009-12-25 DK DK09834989.7T patent/DK2380881T3/en active
- 2009-12-25 CA CA2748251A patent/CA2748251C/fr active Active
- 2009-12-25 WO PCT/JP2009/071529 patent/WO2010074193A1/fr active Application Filing
- 2009-12-25 BR BRPI0924126-4A patent/BRPI0924126B1/pt active IP Right Grant
- 2009-12-25 TW TW098144921A patent/TWI436986B/zh active
- 2009-12-25 JP JP2010544140A patent/JP5143916B2/ja active Active
- 2009-12-25 RU RU2011131048/04A patent/RU2518073C2/ru active
- 2009-12-25 PT PT98349897T patent/PT2380881T/pt unknown
- 2009-12-25 EP EP09834989.7A patent/EP2380881B1/fr active Active
- 2009-12-25 ES ES09834989.7T patent/ES2620446T3/es active Active
- 2009-12-25 US US13/141,301 patent/US8471038B2/en active Active
- 2009-12-25 PL PL09834989T patent/PL2380881T3/pl unknown
- 2009-12-25 KR KR1020117017450A patent/KR101663336B1/ko active IP Right Grant
- 2009-12-25 SI SI200931642A patent/SI2380881T1/sl unknown
- 2009-12-25 AU AU2009331179A patent/AU2009331179B2/en active Active
- 2009-12-25 CN CN200980152533.9A patent/CN102264707B/zh active Active
- 2009-12-25 MX MX2011006904A patent/MX2011006904A/es active IP Right Grant
-
2011
- 2011-06-21 IL IL213690A patent/IL213690A0/en active IP Right Grant
-
2012
- 2012-05-02 HK HK12104295.0A patent/HK1163676A1/xx not_active IP Right Cessation
-
2013
- 2013-05-15 US US13/895,089 patent/US20130303535A1/en active Pending
-
2017
- 2017-03-16 CY CY20171100330T patent/CY1118862T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010074193A1 (fr) | 2010-07-01 |
| AU2009331179A2 (en) | 2011-08-11 |
| DK2380881T3 (en) | 2017-05-08 |
| EP2380881A1 (fr) | 2011-10-26 |
| BRPI0924126A2 (pt) | 2020-08-11 |
| JPWO2010074193A1 (ja) | 2012-06-21 |
| BRPI0924126B1 (pt) | 2021-07-27 |
| MX2011006904A (es) | 2011-07-20 |
| AU2009331179B2 (en) | 2014-09-18 |
| RU2518073C2 (ru) | 2014-06-10 |
| US20110294804A1 (en) | 2011-12-01 |
| CA2748251A1 (fr) | 2010-07-01 |
| KR20110098971A (ko) | 2011-09-02 |
| AU2009331179A1 (en) | 2011-08-11 |
| CY1118862T1 (el) | 2018-01-10 |
| EP2380881B1 (fr) | 2017-01-25 |
| PT2380881T (pt) | 2017-04-18 |
| JP5143916B2 (ja) | 2013-02-13 |
| EP2380881A4 (fr) | 2013-01-09 |
| CA2748251C (fr) | 2016-08-02 |
| US8471038B2 (en) | 2013-06-25 |
| PL2380881T3 (pl) | 2017-07-31 |
| LT2380881T (lt) | 2017-04-10 |
| IL213690A0 (en) | 2011-07-31 |
| US20130303535A1 (en) | 2013-11-14 |
| KR101663336B1 (ko) | 2016-10-06 |
| CN102264707A (zh) | 2011-11-30 |
| SI2380881T1 (sl) | 2017-05-31 |
| TWI436986B (zh) | 2014-05-11 |
| CN102264707B (zh) | 2014-09-03 |
| ES2620446T3 (es) | 2017-06-28 |
| RU2011131048A (ru) | 2013-02-10 |
| TW201028386A (en) | 2010-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1163676A1 (en) | Bicyclic heterocyclic compound | |
| ZA201006511B (en) | Heterocyclic compound | |
| EP2351743A4 (fr) | Composé bicyclique | |
| EP2269990A4 (fr) | Composé hétérocyclique | |
| IL204736A0 (en) | Heterocyclic antiviral compounds | |
| ZA201009183B (en) | Heterocyclic antiviral compounds | |
| EP2202223A4 (fr) | Composé hétérocyclique | |
| IL231955A0 (en) | Tetracycline compounds are substituted at the 7c position with fluorine | |
| EP2334689A4 (fr) | Composé hétérocyclique condensé | |
| EP2138482A4 (fr) | Composé hétérocyclique bicyclique | |
| EP2210876A4 (fr) | Composé hétérocyclique | |
| EP2295406A4 (fr) | Composé hétérocyclique | |
| ZA201104362B (en) | Heterocyclic antiviral compounds | |
| EP2314587A4 (fr) | Composé hétérocyclique azoté | |
| HRP20150932T1 (en) | Heterocyclic compounds | |
| GB0804989D0 (en) | Compound | |
| IL206402A0 (en) | Bicyclic heterocyclic derivative | |
| IL208060A0 (en) | Bicyclic pyrrole compound | |
| EP2298767A4 (fr) | Composé hétérocyclique bicyclique azoté | |
| EP2284159A4 (fr) | Composé 5-hydroxypyrimidine-4-carboxamide | |
| GB0803494D0 (en) | Compound | |
| EP2253633A4 (fr) | Composé hétérocyclique fusionné | |
| EP2154139A4 (fr) | Composé hétérocyclique bicyclique | |
| GB0919816D0 (en) | Heterocyclic compounds | |
| GB0919817D0 (en) | Heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20181225 |